Search
Search
| Catalog Number | Quantity | Packaging |
|---|---|---|
| 268231000 | 100mg | Glass bottle |
General description
• 4-Epichlortetracycline is the hydrochloride salt of 4-Epichlortetracycline, a tetracycline ring structure with a chloride substitution
• 4-Epichlortetracycline hydrochloride (4-Epi-chlortetracycline) is an epimer of chlortetracycline
• 4-Epichlortetracycline suppresses neutrophil activity and dampens the immune response
• Acts as an aminoacyl-tRNA analog to disrupt polypeptide synthesis, reducing bacterial growth Applications
• Can be used for in vitro research on cancer and inflammatory mechanisms
• Intended for use as a selective agent and secondary standard
Literature references
Armstrong, A.W.; Hekmatjah, J.; Kircik, L.H. Oral Tetracyclines and Acne: A Systematic Review for Dermatologists. J Drugs Dermatol. 2020, 19(11), s6-s13. Liou, J.M.; Chen, C.C.; Chang, C.M.; Fang, Y.J.; Bair, M.J.; Chen, P.Y.; Chang, C.Y.; Hsu, Y.C.; Chen, M.J.; Chen, C.C.; Lee, J.Y.; Yang, T.H., Luo, J.C.; Chen, C.Y.; Hsu, W.F.; Chen, Y.N.; Wu, J.Y.; Lin, J.T.; Lu, T.P.; Chuang, E.Y.; El-Omar, E.M.; Wu, M.S. Taiwan Gastrointestinal Disease and Helicobacter Consortium. Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trial. Lancet Infect Dis. 2019,(10), 1109-1120.